APA način citiranja

Rosenstock, J., Jelaska, A., Zeller, C., Kim, G., Broedl, U. C., & Woerle, H. J. (2015). Impact of empagliflozin added on to basal insulin in type 2 diabetes inadequately controlled on basal insulin: A 78‐week randomized, double‐blind, placebo‐controlled trial. Diabetes Obes Metab.

Čikaški stil citiranja

Rosenstock, J., A. Jelaska, C. Zeller, G. Kim, U. C. Broedl, i H. J. Woerle. "Impact of Empagliflozin Added On to Basal Insulin in Type 2 Diabetes Inadequately Controlled On Basal Insulin: A 78‐week Randomized, Double‐blind, Placebo‐controlled Trial." Diabetes Obes Metab 2015.

MLA način citiranja

Rosenstock, J., et al. "Impact of Empagliflozin Added On to Basal Insulin in Type 2 Diabetes Inadequately Controlled On Basal Insulin: A 78‐week Randomized, Double‐blind, Placebo‐controlled Trial." Diabetes Obes Metab 2015.